-
Over 1.7 billion U.S. dollars to help develop ophthalmic gene therapy AbbVie reached cooperation
Time of Update: 2021-10-11
On September 13, 2021, AbbVie and REGENXBIO announced a strategic cooperation agreement to jointly develop and commercialize RGX-314 .
RGX-314 is a potential one-time gene therapy for the treatment of wet age-related macular degeneration (AMD), diabetic retinopathy (DR) and other chronic retinal diseases .
-
Assist stroke patients to restore motor function U.S. FDA approves nerve stimulation therapy
Time of Update: 2021-10-11
This is a non-drug-based rehabilitation system designed to use electrical vagus nerve stimulation (VNS) to treat moderate/severe upper extremity motor deficits associated with chronic ischemic stroke .
-
Innovative ADC therapy for ovarian cancer and triple-negative breast cancer enters the clinic
Time of Update: 2021-10-11
KAAG1 is a tumor-associated antigen that is highly expressed in most ovarian cancers and triple-negative breast cancers.
Reference materials:[1] ADC Therapeutics Doses First Patient in Phase 1 Clinical Trial of ADCT-901 in Advanced Solid Tumors.
com/press-releases/press-release-details/2021 /ADC-Therapeutics-Doses-First-Patient-in-Phase-1-Clinical-Trial-of-ADCT-901-in-Advanced-Solid-Tumors/default.
-
Fudan University mBio published a paper: Discovering new key genes for latent HIV infection
Time of Update: 2021-10-11
Zhu Huanzhang team AIDS is an infectious disease caused by human immunodeficiency virus (HIV) infection that seriously endangers people's lives and health .
-
Reduce the number of injections per year by 86%. Long-acting growth hormone therapy is approved by the US FDA
Time of Update: 2021-10-11
Reference materials:[1] Ascendis Pharma A/S Announces US Food and Drug Administration Approval of SKYTROFA® (lonapegsomatropin-tcgd), the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency.
com/news-release/2021/08/25/2286624/0/en/Ascendis-Pharma-AS-Announces-US-Food-and-Drug-Administration-Approval-of-SKYTROFA-lonapegsomatropin-tcgd-the-First -Once-weekly-Treatment-for-Pediatric-Growth-Hormone-Deficiency.
-
US FDA postpones IgAN therapy Nefecon decision date: potential for disease correction
Time of Update: 2021-10-11
Calliditas Therapeutics recently announced that the US Food and Drug Administration (FDA) has extended the Nefecon (budesonide) New Drug Application (NDA) "Prescription Drug User Fee Act" (PDUFA) target date by 3 months to December 15, 2021 Day .
-
New blood test method can predict patients with high risk of severe new coronary disease
Time of Update: 2021-10-11
According to a recent report on the website of the British "New Scientist" magazine, American researchers have invented a new blood test method that can help by measuring the corresponding antibody levels in the blood of people infected with the new coronavirus (targeting molecules released by dead blood cells and their DNA).
-
Prodigy announces the launch of the world's first protocol analyzer
Time of Update: 2021-10-11
Users can set different trigger conditions to capture specific protocol activities and decode the communication between UFS4.
com/device/ufs-4-0-protocol-analyzer/ You can view a video about this product at the following website: https:// Technovations will showcase PGY-UFS4.
-
Scynexis antifungal drug launched in the U.S. to treat vulvovaginal candidiasis only requires one day of medication
Time of Update: 2021-10-11
The results from two phase 3 clinical studies of the VANISH project show that Brexafemme is effective, safe and well tolerated in the treatment of VVC for one day .
-
High-yield, early maturity, strong disease resistance scientists bred 38 new lily varieties
Time of Update: 2021-10-11
High-yield, early maturity, strong disease resistance scientists bred 38 new lily varietiesScience and Technology Daily News (Reporter Yu Huiyou) cultivated 38 new varieties and varieties of ornamental and edible lilies, developed 1 new product of lily sauce wine, reserved 11 invention patents, and promoted and applied more than 90,000 mu in 8 years .
-
Hotview Bio-New Coronavirus (2019-nCoV) Antigen Self-Test Kit was registered by MHRA in the UK
Time of Update: 2021-10-11
On September 23, Hotview Bio issued an announcement stating that the company's new coronavirus (2019-nCoV) antigen self-test kit has recently been registered by the British Medicines and Health Products Administration (hereinafter referred to as "UK MHRA") .
-
ThinkSono DVT testing software results announced
Time of Update: 2021-10-11
Researchers from the University of Oxford, Imperial College and University of Sheffield collaborated with technology company ThinkSono (led by Fouad Al-Noor and Sven Mischkewitz) to train machine learning AI algorithms (AutoDVT) to distinguish DVT patients from non-DVT patients .
-
Nasopharyngeal cancer treatment "Chinese plan" or rewrite global standards
Time of Update: 2021-10-11
On September 15, the results of the first-line treatment of relapsed/metastatic nasopharyngeal carcinoma (JUPITER-02 study) with teriprizumab combined with chemotherapy led by Professor Xu Ruihua, director of the Sun Yat-sen University Cancer Center The journal "Nature Medicine", this is the first time that "Nature Medicine" has recommended China's innovative drug research on the cover in the past 26 years .
-
Immune stimulant coupled with monoclonal antibody Cinda Biosciences collaborates to develop innovative anti-cancer therapies
Time of Update: 2021-10-11
The two parties will combine Cinda's proprietary antibody drug portfolio and R&D capabilities for undisclosed tumor targets, and Bolt's advanced ISAC technology and expertise in the field of myeloid cells to jointly develop three new anti-cancer immunotherapy drugs, which are expected to provide patients Bring significant benefits .
-
Concerned about rare diseases, Nestlé’s donation of Xiaobaitai can provide nutritional support for girls with intestinal Behcet's disease
Time of Update: 2021-10-11
Beijing, September 17, 2021/PRNewswire/ - On September 14, a special donation ceremony was held at the Red Cross Society of Jingxian County, Anhui Province - Nestlé Health Sciences provided an intestinal Behcet's disease in Jingxian County 'S girl donated "Xiaobai Taineng" special medical purpose all-nutrition formula food for nutritional treatment, and I wish her a speedy recovery .
-
The new coronavirus vaccine is effective against the mutant strain in animal trials
Time of Update: 2021-10-11
By displaying the protein of the new coronavirus on the surface of this virus-like particle, researchers have developed this new vaccine, which can be recognized by the immune system of mammals but is not infectious .
-
Does large-scale genetics research on autism make sense?
Time of Update: 2021-10-11
jpg"/>            A large study based on genetics and autism spectrum disorder (ASD) in the United Kingdom (the Spectrum 10K study aims to collect the DNA of 10,000 autistic patients and their families) was suspended because some people criticized the study for failing to solve the problem.
-
The most "strong" mutant strain "Mu" is here!
Time of Update: 2021-10-11
(1) Natural products as the starting point for lead compoundsIn the protracted challenge of new drug discovery, current medicinal chemistry gradually abandons simple planar molecular structures, and instead emphasizes three-dimensional design.
-
The first oral therapy!
Time of Update: 2021-10-11
On September 15, Takeda announced that the FDA has accelerated the approval of Exkivity (mobocertinib) for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) adults who carry EGFR exon 20 insertion mutations and undergo disease progression after platinum-based chemotherapy.
-
Artificial intelligence 3D printing technology solves the "invisible" problems in orthopedic surgery
Time of Update: 2021-10-11
Recently, Zhou Jianlin’s team, associate professor of bone and joint surgery at Wuhan University People’s Hospital, used artificial intelligence 3D printing technology to print out Aunt Zhang’s true positioning model of the acetabular and iliac bone defect, and through the customized guide "navigation" surgery, she accurately performed tumor resection.